Vecuronium neuromuscular block in patients with malignant obstructive jaundice.
Baraka
A
A
D000368:Aged; D001650:Bile Duct Neoplasms / Q000150:complications; D002779:Cholestasis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D008099:Liver / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009469:Neuromuscular Junction / Q000187:drug effects*; D010190:Pancreatic Neoplasms / Q000150:complications; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors; D014673:Vecuronium Bromide / Q000378:metabolism / Q000494:pharmacology
D014673:Vecuronium Bromide